KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Clorox (CLX) Shares Outstanding (Diluted Average) (2016 - 2025)

Clorox (CLX) has 17 years of Shares Outstanding (Diluted Average) data on record, last reported at $121.9 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 2.2% year-over-year to $121.9 million; the TTM value through Dec 2025 reached $121.9 million, down 2.2%, while the annual FY2025 figure was $124.3 million, 0.41% changed from the prior year.
  • Shares Outstanding (Diluted Average) reached $121.9 million in Q4 2025 per CLX's latest filing, down from $123.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $127.3 million in Q2 2021 and bottomed at $121.9 million in Q4 2025.
  • Average Shares Outstanding (Diluted Average) over 5 years is $124.3 million, with a median of $124.2 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): dropped 3.64% in 2021, then increased 0.6% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $123.9 million in 2021, then rose by 0.03% to $124.0 million in 2022, then grew by 0.55% to $124.6 million in 2023, then increased by 0.02% to $124.7 million in 2024, then fell by 2.2% to $121.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $121.9 million in Q4 2025, $123.0 million in Q3 2025, and $124.3 million in Q2 2025.